Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine

Brain Research Reviews

Volumn 35, Issue 1, 2001, Pages 20-35

  Mitsikostas, Dimos D ^a   Sanchez del Rio, Margarita ^b  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

5 HT; Animal model; c fos; GABA; Glutamate; Migraine; Neurokinin; Pain

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALKALOID; AMPA RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; METABOTROPIC RECEPTOR; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROKININ A; RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN 2B RECEPTOR; SUBSTANCE P; VANILLOID RECEPTOR;

ANIMAL MODEL; ELECTROSTIMULATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; INFLAMMATION; MECHANICAL STIMULATION; MENINX; MIGRAINE; NERVE CONDUCTION; NERVE ENDING; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION; STIMULATION; SUPERIOR SAGITTAL SINUS; TRIGEMINAL NUCLEUS;

ANIMALS; DISEASE MODELS, ANIMAL; MIGRAINE DISORDERS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, CELL SURFACE; TRIGEMINAL CAUDAL NUCLEUS;

EID: 0035096199     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00048-5     Document Type: Review

References (188)

1. Receptor and ion channel nomenclature
2. Nitric oxide signaling in pain and nociceptor sensitization in the rat
3. The possible relationship of serotonin to the migraine syndrome
4. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro
5. NKl receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea
6. Sensitization of pain pathways in the spinal cord: Cellular mechanisms
7. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey
8. Recent developments in tachykinin NKl receptor antagonists: Prospects for the treatment of migraine headache
9. Excitatory amino release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat
10. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the rat
11. Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat
12. Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat
13. 5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: A microiontophoretic study
14. Co-localization of 5-HT1B- and 5-HT1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphe nucleus: A double labeling in situ hybridization histochemistry study
15. RS-127445, a selective 5-HT2B receptor antagonist, blocks mCPP-evoked plasma protein extravasation in dura mater and capsaicin-evoked c-fos expression in trigeminal nucleus caudalis
16. RS-127445: A selective, high affinity, orally bioavailable 5-HT2B receptor antagonist
17. The 'ABC' of GABA receptors
18. No contractile effect for 5-HT1D and 5-HT1D receptor agonists in human and bovine cerebral arteries: Similarity with human coronary artery
19. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
20. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation
21. Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia
22. An association between migraine and cutaneous allodynia
23. A capsaicin-receptor homologue with a high threshold for noxious heat
24. Increased brain serotonin synthesis in migraine
25. The role of 5-HT(1A)-receptors in fentanyl-induced bulbospinal inhibition of a spinal withdrawal reflex in the rabbit
26. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig
27. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: Molecular and pharmacologic characterization
28. Fos and Jun: The AP-1 connection
29. Structure of the FBJ murine osteosarcoma virus genome: Molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells
30. FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product
31. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracistemal capsaicin
32. Attenuation by butalbutal of capsaicin induced c-fos-like immunoreactivity in trigeminal nucleus caudalis
33. The actions of valproate and neurosteroids in a model of trigeminal pain
34. The non-peptide neurokinin-l antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation
35. Suppression by the sumatriptan analogue, CP-122, 288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin
36. Effects of PNU-109, 291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis
37. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord
38. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells
39. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation
40. Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: A c-Fos study in rat
41. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord
42. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer
43. Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation
44. Expression of calcitonin gene-related peptide-l receptor mRNA in human trigeminal ganglia and cerebral arteries
45. Neuropeptides in migraine and cluster headache
46. Triptan vascular reactivity in human isolated coronary and cranial arteries and its relevance to clinical administration of these drugs
47. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain
48. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monanine synthesis in the rat brain in vivo
49. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: Studies in 5-HT1B knock-out mice
50. Transmitters involved in antinociception in the spinal cord
51. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception
52. Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms
53. Release of sensory neuropeptides from dural venous sinuses of guinea pig
54. Trans-synaptic regulation of gene expression
55. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
56. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/1D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine?
57. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-fos immunocytochemical study
58. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: A central action in migraine?
59. Differential effects of low dose CP122, 288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat
60. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation
61. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxytryptanille (5-HT(1B/1D)) receptors
62. Neural processing of craniovascular pain: A synthesis of the central structures involved in migraine
63. Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism
64. Cortical spreading depression-associated hyperemia in rats: Involvement of serotonin
65. Ineffectiveness of neurokinin-1 antagonist in acute migraine: A crossover study
66. Study of the analgesic effect of lanepitant in patients with osteoarthritis pain
67. Migraine treatment with selective 5-HT1F receptor agonist (SSOFRA) LY334370
68. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells
69. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
70. Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites
71. 5-HT1 receptors mediating contraction in bovine cerebral arteries: A model for human cerebrovascular '5-HT1D beta' receptors
72. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME
73. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat
74. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study
75. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism
76. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
77. Glutamate receptor channels in rat DRG neurons: Activation by kainate and quisqualate and blockade of desensitization by Con A
78. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation
79. Electron microscopy of immunoreactivity patterns for glutamate and gamma-aminobutyric acid in synaptic glomeruli of the feline spinal trigeminal nucleus (Subnucleus Caudalis)
80. Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression
81. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats
82. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilation of human cerebral arteries concomitant with activation of adenylyl cyclase
83. Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebo-controlled crossover study
84. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: Relationship to c-fos induction
85. Serotonin in migraine: Theories, animal models and emerging therapies
86. 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs
87. Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner
88. Activation of the trigeminovaseular system by mechanical distension of the superior sagittal sinus in the cat
89. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption
90. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat
91. Human arterial constrictor serotonin receptors
92. Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat
93. Lipopolysaccharide-induced hyperalgesia of intracranial capsaicin sensitive afferents in conscious rats
94. Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: A putative mechanism of 5-HT3 induced anti-nociception
95. Effect of serotonin in migraine patients
96. Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: A possible model of migraine headache
97. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model
98. Simultaneous activation of N-methyl-D-aspartate and neurokinin-1 receptors modulates c-Fos and Zif/268 expression in the rat trigeminal nucleus caudalis
99. Autoregulation of fos: The dyad symmetry element as the major target of repression
100. Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation
101. Pathophysiology of the migraine aura. The spreading depression theory
102. Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats
103. Spreading depression of activity in cerebral cortex
104. A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation
105. Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva
106. Substance P receptor (NK1)-immunoreactive neurons projecting to the periaqueductal gray: Distribution in the spinal trigeminal nucleus and the spinal cord of the rat
107. A-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges
108. Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries
109. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
110. Differential distribution of 5-HT1D- and 5-HTB-immunoreactivity within the human trigeminocerebrovascular system: Implications for the discovery of new antimigraine drugs
111. Serotonergic modulation of the responses to excitatory amino acids of rat dorsal horn neurons in vitro: Implications for somatosensory transmission
112. Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings
113. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain
114. Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache
115. Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification
116. Inhibition of endothelium-dependent vasorelaxation by arginine analogues: A pharmacological analysis of agonist and tissue dependence
117. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater
118. UK-14,304, R(-)-alpha-methylhistamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms
119. Ultrastructural characterization of substance-P-immunoreactive synaptic terminals in the cat's normal and rhizotomized trigeminal subnucleus caudalis
120. Cortical spreading depression recorded from the human brain using a multiparainetric monitoring system
121. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression
122. Triptans and migraine: Which drug for which patient?
123. The distribution of substance P-, enkephalin- and dynorphin-immunoreactive neurons in the medulla of the rat and their contribution to bulbospinal pathways
124. Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat
125. Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord
126. Serotonin's central action in migraine
127. Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis
128. Intracisternal capsaicin induces c-fos immunoreactivity within trigeminal nucleus caudalis in mouse
129. Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis
130. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis
131. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
132. Comment on Ingvardsen et al.
133. A negative clinical study in the search for a migraine treatment
134. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms
135. Polyclonal antibodies against the rat NK1 receptor: Characterization and localization in the spinal cord
136. Induction of c-fos gene and protein by growth factors precedes activation of c-myc
137. Contractile 5-HT1B receptors in human cerebral arteries: Pharmacological characterization and localization with immunocytochemistry
138. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
139. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space
140. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges
141. On the role of 5-HT1B/1D receptors in modulating transmission in a spinal reflex pathway in the decerebrated rabbit
142. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors
143. Some aspects of cardiovascular regulation in man
144. Glutamate receptors in the mammalian central nervous system
145. Imaging neurogenic inflammation in patients with migraine headaches
146. Antimigraine drug interactions with serotonin receptor subtypes in human brain
147. The non-peptide NK-1 receptor antagonist LY 3 03870 inhibits neurogenic dural inflammation in guinea pigs
148. Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine
149. The activity of 205,171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system
150. Spinal antinociceptive effects of excitatory amino acid antagonists: Quisqualate modulates the action of N-methyl-D-aspartate
151. The CREB-binding protein (CBP) cooperates with the serum response factor for transactivation of the c-fos serum response element
152. Experimental studies in headache
153. Vasoconstriction in human isolated middle meningeal arteries: Determining the contribution of 5-HT1B- and 5-HT1F-receptor activation
154. Capsaicin and blood-brain barrier permeability
155. Perivascular nerves contribute to cortical spreading depression-associated hyperemia in rats
156. No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double-blind, placebo-controlled clinical trials
157. Expression of c-fos protein in brain: Metabolic mapping at the cellular level
158. Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion
159. Neurovascular cortical spreading phenomenon during spontaneous visual aura
160. AMPA, KA and NMDA receptors are expressed in the rat DRG neurones
161. Activation of meningeal 5-HT2B receptors: An early step in the generation of migraine headache?
162. Transcriptional activation encoded by the v-fos gene
163. c-fos expression and (14C) 2-deoxyglucose uptake in the caudal cerebellum of the rat during motor/sensory cortex stimulation
164. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370
165. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats
166. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats
167. More on mCPP and migraine
168. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord
169. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat
170. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors
171. Response of brainstem trigeminal neurons to electrical stimulation of the dura
172. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat
173. Anatomical properties of brainstem trigeminal neurons that respond to electrical stimulation of dural blood vessels
174. Sensitization of meningeal sensory neurons and the origin of headaches
175. Somatotopic and laminar organization of fos-like immunoreactivity in the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat
176. GABA(A) receptor-mediated effects on expression of c-Fos in rat trigeminal nucleus following high- and low-intensity afferent stimulation
177. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat
178. Neuropeptides in the cerebral circulation
179. jun B, c-jun, jun D and c-fos mRNAs in nucleus caudalis neurons: Rapid selective enhancement by afferent stimulation
180. Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamate
181. Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland
182. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles
183. Effect of nitric oxide on substance P release from the peripheral endings of primary afferent neurons
184. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl-tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine-1B receptors
185. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides
186. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase
187. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats